NeuroMetrix, Inc. (NASDAQ:NURO)
CAPS Rating:
The Company designs, develops and sells proprietary medical devices used to help physicians diagnose neuropathies and neurovascular disease.
Just Fool it
The Company designs, develops and sells proprietary medical devices used to help physicians diagnose neuropathies and neurovascular disease.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
has been hammered by the market despite pretty good news here and there. Down 30% in the last few months so it should spring back up in the next year.